Novel piperazinoamide compound
A compound, selected technology, applied in organic chemistry, drug combination, cardiovascular system diseases, etc.
Active Publication Date: 2010-10-06
GUANGZHOU INST OF BIOMEDICINE & HEALTH CHINESE ACAD OF SCI
View PDF3 Cites 24 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Formula I
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 13
Embodiment 23
Embodiment 3
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention relates to a novel piperazinoamide compound, a preparation method thereof, and application thereof in treating neurodegenerative disease, mental disease, epilepsy, convulsion, apoplexy, and the like. The structure of the piperazinoamide compound is shown as formula I. The in vitro tests verify that the piperazinoamide compound has an effect of inhibiting cells BV2 from secreting IL-1beta effectively, and has high safety. The formula I is shown in the description.
Description
technical field The present invention relates to a novel piperazine amide compound, a preparation method thereof, a composition containing the substance, and the compound as a neuroinflammation inhibitor to treat or prevent neurodegenerative diseases, such as Alzheimer's disease and Parkinson's The use of antipsychotic, antiepileptic, anticonvulsant and antistroke diseases. Background technique Alzheimer's disease, also known as Alzheimer's disease (Alzheimer's disease, AD), is a central nervous system degenerative disease mainly characterized by progressive cognitive impairment and memory impairment. The clinical manifestations of the disease are short-term memory dysfunction, followed by persistent mental decline, loss of judgment and reasoning ability, aphasia, and movement disorders. Its pathological features are a large number of senile plaques (SPs) and neurofibrillary tangles (neurofibrilary tangles, NFTs). There are two main types of drugs currently on the market: ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D237/24C07D403/12C07D401/12C07D239/72C07D207/34C07D333/38C07D231/56C07D231/14A61K31/501A61K31/506A61K31/517A61K31/496A61P25/28A61P25/18A61P25/08A61P9/10A61P25/16
Inventor 胡文辉钟桂发曾少高杨玲徐宏江
Owner GUANGZHOU INST OF BIOMEDICINE & HEALTH CHINESE ACAD OF SCI
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com